29
Sat, Apr
19 New Articles

Top Stories

Amgen announced that The Lancet published results from a Phase 3 randomized, double-blind, placebo-controlled study of Nplate in children with symptomatic immune thrombocytopenia.

Sanofi and Regeneron Pharmaceuticals, Inc announced that Health Canada approved KevzaraTM (sarilumab), an interleukin-6 (IL-6) receptor antibody.

H. Lundbeck A/S is collaborating with IBM's Watson Health to accelerate the development of innovative medicines to treat psychiatric and neurological disorders.

Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM) manufacture at its facility in Research Triangle Park, North Carolina, USA.

Inovio Pharmaceuticals, Inc. announced preliminary results from the expanded stage of its phase I study, EBOV-001. The expanded study examined different regimens of its Ebola DNA vaccine INO-4201 using intradermal (skin) administration.

LEO Pharma today announced positive results from a Phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with moderate to severe atopic dermatitis (AD), a serious and chronic form of eczema. 

Johnson Matthey, a global specialty chemicals company and provider of advanced process technologies, and Rennovia Inc., a privately held company that develops novel catalysts and processes for the cost advantaged production of chemical products from renewable feedstocks.

Aldevron, a leading biotechnology contract manufacturing and development organization, is now using a 30-liter single-use fermentation system for manufacturing nucleic acids and proteins.

Beximco Pharmaceuticals Limited the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, announces the creation of a joint venture with BioCare Manufacturing Sdn Bhd based in Malaysia, as the Company’s first overseas manufacturing collaboration.

Sharp Clinical Services (Sharp), part of UDG Healthcare plc , has announced a £9 million  investment to fund a new multiple-phase pharmaceutical manufacturing, packaging and distribution facility in Wales.

Mettler-Toledo, a market leader in product inspection technology, will present a comprehensive range of solutions and upgradesat interpack 2017 (www.mt.com/interpack17) for both the food and pharmaceutical sectors, as well as providing a wealth of technical knowledge via its experts at the stand.

Fluorescing UV inks offer a number of advantages, including high print quality, improved durability and enhanced productivity.